Loading...
XNAS
SNES
Market cap7mUSD
Jul 09, Last price  
1.39USD
1D
0.36%
1Q
-13.44%
Jan 2017
-100.00%
IPO
-100.00%
Name

Senestech Inc

Chart & Performance

D1W1MN
XNAS:SNES chart
P/E
P/S
3.31
EPS
Div Yield, %
Shrs. gr., 5y
664.80%
Rev. gr., 5y
53.81%
Revenues
2m
+19.60%
199,000241,000318,00052,000297,000143,000258,000576,0001,019,0001,193,0001,857,0002,221,000
Net income
-6m
L+3.22%
-7,200,000-18,173,000-10,795,000-12,286,000-11,908,000-10,018,000-7,937,000-8,268,000-9,695,000-7,710,000-6,184,000-6,383,000
CFO
-6m
L-4.69%
-2,527,000-3,666,000-6,696,000-9,321,000-9,129,000-8,058,000-7,108,000-7,779,000-8,577,000-7,566,000-6,033,000-5,750,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
IPO date
Dec 08, 2016
Employees
29
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT